Epithelial cell differentiation of human mesenchymal stromal cells
AssigneeYale University
InventorsLaura E. Niklason, Julio J. Mendez
Life of this patent
Estimating the term…
Abstract
The present invention relates to the discovery that different stem cell types (e.g., bone marrow-derived mesenchymal stem cells (BM-MSC) and adipose-derived mesenchymal stem cells (AT-MSC)) undergo large changes in lung epithelial marker expression depending on the substrate on which they are cultured. The present invention includes methods and compositions for differentiating of mesenchymal stem cells, such as bone marrow and adipose tissue mesenchymal stem cells, into lung cells, populations of lung cells, and methods of alleviating or treating a lung defect in a subject in need thereof.
Claims5
A method of differentiating an adipose tissue-derived mesenchymal stem cell (AT-MSC) into a lung cell, the method comprising:
- seeding the AT-MSC on an ex vivo substrate;
- and
- exposing the AT-MSC seeded substrate to small airway growth medium that comprises at least one of retinoic acid and human epidermal growth factor, thereby differentiating the AT-MSC into a lung cell that expresses at least one epithelial marker, wherein the lung cell exhibits at least one characteristic of a Clara cell, wherein the at least one characteristic of a Clara cell comprises expression of Clara cell secretory protein (CCSP).
A method of differentiating a bone marrow derived mesenchymal stem cell (BM-MSC) into a lung cell that exhibits at least one characteristic of a type II alveolar epithelial cell, the method comprising:
- seeding the BM-MSC on an ex vivo substrate, wherein the substrate is a decellularized lung tissue;
- and
- exposing the BM-MSC seeded substrate to small airway growth medium that comprises at least one of retinoic acid and human epidermal growth factor, thereby differentiating the BM-MSC into a lung cell that exhibits at least one characteristic of a type II alveolar epithelial cell,
- wherein the at least one characteristic of a type II alveolar epithelial cell is expression of cytokeratin-5.
Dependencies are inferred from the claim text.